Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Rey, a mental health subsidiary of UK-based digital mental health therapy developer Oxford VR, has raised $10m in series A funding co-led by Oxford Sciences Innovation, the venture fund of University of Oxford, and Optum Ventures, according to Forbes. The company has now secured $26m in its series A round, Forbes said, without offering further details. Rey launched three months ago and its parent company is a spinout of University of Oxford.

Micropep Technologies, a France-based agricultural biotech spinout of Paul Sabatier University and CNRS, has raised €8.5m ($10m) in an oversubscribed series A round led by Supernova Invest, with participation from FMC Ventures, and existing investors Sofinnova Partners and IRDI Capital Investissement. The spinout raised $5m in its series A round in 2018.

Amaroq Therapeutics, a New Zealand-based RNA therapy developer spun out of University of Otago, has raised NZ$14m ($9.7m) in a round featuring tech transfer…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).